Federal contract award
W81XWH20F0302
DEP DRUG DEVELOPMENT FOE ET AT WRAIR
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | ARMY MED RES ACQ ACTIVITY |
| NAICS | 541712 |
| PSC | AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH |
| Parent award / vehicle | GS00Q14OADU414 |
| Set-aside | Not reported |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $12.7M |
| Current contract value | $19.7M |
| Potential contract value / ceiling | $21.1M |
| Start date | Aug 27, 2020 |
| Current end date | Aug 26, 2023 |
| Potential end date | Aug 26, 2023 |
| Latest award activity | Apr 14, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 22 of 22 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Apr 14, 2026 | P00021 | $2.6K | EXPERIMENTAL THERAPEUTICS RESEARCH SUPPORT |
| Mar 20, 2026 | P00020 | $-99.6K | EXPERIMENTAL THERAPEUTICS RESEARCH SUPPORT |
| Feb 23, 2024 | P00019 | $-312.4K | EXPERIMENTAL THERAPEUTICS SUPPORT SERVICES |
| Aug 7, 2023 | P00018 | $-325.8K | DRUG RESEARCH AND DEVELOPMENT |
| Feb 13, 2023 | P00017 | $0 | DEP DRUG DEVELOPMENT SERVICES AT WALTER REED ARMY INSTITUTE OF RESEARCH |
| Feb 2, 2023 | P00016 | $2.6M | RESEARCH AND DEVELOPMENT - DRUG DEVELOPMENT AT WRAIR. |
| Sep 17, 2022 | P00015 | $1.5M | FUNDING FOR OP2 DEP DRUG DEVELOPMENT AT WRAIR |
| Aug 31, 2022 | P00014 | $-1.3M | THIS REQUIREMENT IS IN SUPPORT OF WRAIR ET BRANCH FOR PROVIDE SUPPORT TO INVESTIGATORS FOR NEW DRUG DISCOVERY AND DEVELOPMENT IN ALL DEPARTMENTS OF EXPERIMENTAL THERAPEUTICS RESEARCH SUPPORT. THIS ACTION IS TO DEOBLIGATE EXCESS FUNDS. |
| Jul 22, 2022 | P00013 | $412.3K | FUNDING FOR OP2 DEP DRUG DEVELOPMENT AT WRAIR |
| Mar 25, 2022 | P00012 | $973.2K | CHANGES TO PWS AND WORK ALLOCATION IN CLIN'S FOR DEP DRUG DEVELOPMENT AT WRAIR |
| Feb 9, 2022 | P00011 | $923.5K | EXERCISE OPTION PERIOD 2 FOR DEP DRUG DEVELOPMENT AT WRAIR |
| Feb 1, 2022 | P00010 | $25.0K | ADDING FUNDS FOR ODC'S ON OP1 FOR DEP DRUG DEVELOPMENT AND DISCOVERY AT WRAIR. |
| Nov 24, 2021 | P00009 | $210 | FUNDING FOR OP1 DEP DRUG DEVELOPMENT AT WRAIR |
| Sep 15, 2021 | P00008 | $231.1K | FUNDING FOR DEP DRUG DEVELOPMENT OPTION PERIOD 1 AT WRAIR |
| Jun 14, 2021 | P00007 | $100.0K | FUNDING FOR OP1 DEP DRUG DEVELOPMENT AT WRAIR |
| May 21, 2021 | P00006 | $1.1M | FUNDING FOR OP1 DEP DRUG DEVELOPMENT ET AT WRAIR |
| May 7, 2021 | P00005 | $0 | CHANGES TO TASKS ALLOCATION IN PWS AND CLIN'S FOR DEP DRUG DEVELOPMENT ET AT WRAIR |
| Apr 22, 2021 | P00004 | $-62.3K | DE-OBLIGATION OF FUNDS DUE TO OVER FUNDING ON MOD 2 FOR DRUG DEVELOPMENT AND DRUG DISCOVERY AT WRAIR. |
| Mar 8, 2021 | P00003 | $3.9M | EXERCISE OPTION PERIOD 1 DEP DRUG DEVELOPMENT ET AT WRAIR. |
| Feb 12, 2021 | P00002 | $388.8K | ADDING THE EXTRA MONTH OF COST TO THE DEP DRUG DEVELOPMENT (IT WAS AWARDED WITH AN EXTRA MONTH FROM PROPOSAL) FOR WRAIR. |
| Aug 27, 2020 | P00001 | $1.9M | FUNDING THAT WAS MISSED ON AWARD FOR ET DEP DRUG DEVELOPMENT AT WRAIR. |
| Aug 25, 2020 | 0 | $571.8K | DEP DRUG DEVELOPMENT FOE ET AT WRAIR |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.